Database

Startups

Main Industry
Biotechnology
Main Product/Service
THE ONE BIOPHARMACEUTICAL CO., LTD. has launched a series of natural herbal health supplements (such as Gan Wei and Sheng Wei Compound Herbal Capsules, etc.), which have demonstrated outstanding efficacy in clinical trial data and clinical efficacy research. Through the solid medical evidence and research and development of its scientific research team, THE ONE BIOPHARMACEUTICAL CO., LTD. has developed nine new drugs and health products, with subsequent series of products also continuously under development. These products are highly favored by the public and possess extremely high market value.
The content above was translated by Ai
Founded Year
2016
Unified Business No.
55954888
Status
Active
Number of Employees
0
Total Paid-in Capital
70,000,000 (NT$)
Location of Company
Taiwan , Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups. Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed. Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
About the Company
THE ONE BIOPHARMACEUTICAL CO., LTD. takes it as its mission to develop therapeutic drugs and health foods targeting cancer and chronic diseases using scientific methods, hoping to provide brand new treatment methods for cancer and chronic disease patients worldwide. "Benefiting the world and caring for life" is the founding purpose of THE ONE BIOPHARMACEUTICAL CO., LTD. THE ONE BIOPHARMACEUTICAL CO., LTD. has assembled a top product R&D advisory team composed of Academicians of Academia Sinica, well-known domestic and international academic experts, scholars, physicians, and PhD scientists, to meticulously develop targeted new drugs for liver cancer that are suitable for the physical constitution of Asians, as well as botanical new drugs developed based on natural Chinese herbal medicines. In addition to disease-oriented R&D aspects, the company also emphasizes the concept of "the superior doctor prevents disease before it occurs" in preventive medicine, conducting research directed toward clinical evidence-based medicine to exert the spirit of preventive medicine and effectively address the prevention and occurrence of diseases.


The content above was translated by Ai
more ↓

Similar Companies

回頁面最頂端